Press Releases

Date Title and Summary
Toggle Summary First CyberKnife® Full-Body Radiosurgery System in Manhattan Now Treating Patients
SUNNYVALE, Calif. , Nov. 18, 2014 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today that the first CyberKnife ® System in Manhattan is now treating patients at Winthrop University Hospital's NYCyberKnife Center. Winthrop's decision to install the latest generation CyberKnife M6™
Toggle Summary Accuray to Participate in Brean Capital's 2014 Life Science Conference
SUNNYVALE, Calif. , Nov. 10, 2014 (GLOBE NEWSWIRE) -- Accuray Incorporated (Nasdaq:ARAY), announced today that its management is scheduled to participate in the Brean Capital 2014 Life Science Conference in New York City on Monday, November 24, 2014 .
Toggle Summary Accuray Reports Financial Results for First Quarter of Fiscal Year 2015
SUNNYVALE, Calif. , Oct. 29, 2014 (GLOBE NEWSWIRE) -- Accuray Incorporated (Nasdaq:ARAY) announced today financial results for the first fiscal quarter ended September 30, 2014 . First Quarter Highlights Gross orders of $58.8 million Total revenue of $82.4 million , an increase of 7% from the first
Toggle Summary Accuray to Report Financial Results for First Quarter Fiscal 2015
SUNNYVALE, Calif. , Oct. 8, 2014 (GLOBE NEWSWIRE) -- Accuray Incorporated (Nasdaq:ARAY) announced today that it will report results for its first quarter ended September 30, 2014 on October 29, 2014 after the market closes. A conference call to review the results will begin at 1:30 p.m.
Toggle Summary Studies Support Growing Use of the Accuray TomoTherapy® System for Breast Cancer to Improve Tumor Control with Reduced Toxicities
Additional Data Demonstrate Accuray TomoTherapy and CyberKnife® Systems Provide Precise Dose Delivery and Tumor Management SUNNYVALE, Calif. , Sept. 18, 2014 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today that studies presented at the 56th Annual American Society for Radiation
Toggle Summary Accuray Signs Exclusive Radiation Therapy Solutions Contract With Premier, Inc.
Three-Year Agreement Provides Accuray With Access to More Than 3,000 Member Hospitals for the CyberKnife(R) M6(TM) and TomoTherapy(R) HDA(TM) Systems SUNNYVALE, Calif. , Sept. 9, 2014 (GLOBE NEWSWIRE) -- Accuray Incorporated (Nasdaq:ARAY) announced today that it has been awarded a new, exclusive
Toggle Summary Accuray Reports Financial Results for Fourth Quarter of Fiscal Year 2014 and Introduces Fiscal 2015 Guidance
Achieves Full Year Net Order Guidance Strong Revenue, Margin Expansion and Adjusted EBITDA Growth SUNNYVALE, Calif. , Aug. 21, 2014 (GLOBE NEWSWIRE) -- Accuray Incorporated (Nasdaq:ARAY) announced today financial results for the fourth fiscal quarter and fiscal year ended June 30, 2014 .
Toggle Summary Accuray Incorporated to Present at 2014 Morgan Stanley Global Healthcare Conference
SUNNYVALE, Calif. , Aug. 19, 2014 (GLOBE NEWSWIRE) -- Accuray Incorporated (Nasdaq:ARAY), announced today that its management is scheduled to present at the 2014 Morgan Stanley Global Healthcare Conference in New York City on Monday, September 8, 2014 at 12:50 p.m. ET / 9:50 a.m. PT .
Toggle Summary Accuray to Report Financial Results for Fourth Quarter and Year End Fiscal 2014
SUNNYVALE, Calif. , Aug. 7, 2014 (GLOBE NEWSWIRE) -- Accuray Incorporated (Nasdaq:ARAY) announced today that it will report results for its fourth quarter and fiscal year ended June 30, 2014 on Thursday, August 21, 2014 after the market closes. A conference call to review the results will begin at
Toggle Summary Latest MD Buyline Report Shows Highest User Satisfaction Composite Ratings for Accuray Incorporated
SUNNYVALE, Calif. , July 17, 2014 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today that its CyberKnife ® and TomoTherapy ® Systems have received the highest composite overall user satisfaction rating among radiation treatment delivery systems in the U.S., according to the Q2 2014

*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.